EUVIMEDEUVIMED entdecken
Crossref

Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy

Mohsen M. Maher, Osama M. Hetta, Wesam A. Ibrahim, Ahmed M. El-Ghandour

Ain Shams Medical Journal · 2013

DOI: 10.12816/0013822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ain Shams Medical Journal, 2013. Verfasst von Mohsen M. Maher und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Maher, M. M., Hetta, O. M., Ibrahim, W. A., & El-Ghandour, A. M. (2013). Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy. Ain Shams Medical Journal. https://doi.org/10.12816/0013822

Vancouver

Maher MM, Hetta OM, Ibrahim WA, El-Ghandour AM. Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy. Ain Shams Medical Journal. 2013. doi:10.12816/0013822

BibTeX
@article{Maher2013,
  author = {Maher, Mohsen M. and Hetta, Osama M. and Ibrahim, Wesam A. and El-Ghandour, Ahmed M.},
  title = {Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy},
  journal = {Ain Shams Medical Journal},
  year = {2013},
  doi = {10.12816/0013822}
}
Kostenlos starten →